Literature DB >> 20849205

Fundal height: a useful screening tool for fetal growth?

Teresa N Sparks1, Yvonne W Cheng, Blake McLaughlin, Tania F Esakoff, Aaron B Caughey.   

Abstract

OBJECTIVE: To determine the utility of fundal height in screening for small-for-gestational-age (SGA) and large-for-gestational-age (LGA) neonates at term. STUDY
DESIGN: This was a retrospective cohort study of 3627 women at University of California, San Francisco from 2002 to 2006 with term, singleton pregnancies specifically examining the 448 who had third trimester ultrasounds for size unequal to dates by fundal height. χ(2) analyses determined the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of fundal height as a screening tool for abnormal intrauterine growth.
RESULTS: The sensitivity of fundal height was 16.6% for detecting actual birthweight (BWt) > 90th percentile (p < 0.001) and 17.3% for < 10 th percentile (p < 0.001). Specificity ranged from 92.4 to 95.4%. Significant differences existed among subgroups by maternal weight, parity, age, and ethnicity. Sensitivity was lower for SGA among overweight/obese women but higher among multiparous women. Additionally, women ≥ 35 years showed higher sensitivity for extreme LGA, and several notable differences were found by ethnicity such as higher sensitivity for extreme LGA among Caucasian women.
CONCLUSION: The sensitivity of fundal height for detecting abnormal intrauterine growth was less than 35% for all subgroups, although specificity was more ideal at >90%. Other modalities should be considered to screen for growth abnormalities.

Entities:  

Mesh:

Year:  2010        PMID: 20849205     DOI: 10.3109/14767058.2010.516285

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  20 in total

1.  Diagnostic accuracy of fundal height and handheld ultrasound-measured abdominal circumference to screen for fetal growth abnormalities.

Authors:  Adriane F Haragan; Thomas C Hulsey; Angela F Hawk; Roger B Newman; Eugene Y Chang
Journal:  Am J Obstet Gynecol       Date:  2015-03-25       Impact factor: 8.661

2.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

3.  Prenatal Prediction of Fetal Growth Restriction and Postnatal Outcomes by Ultrasound Assessment of Fetal Myocardial Performance Index and Blood Flow Spectrum.

Authors:  Yanchun Ma; Chunmin Li; Yan Wang; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-05       Impact factor: 2.650

4.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

5.  Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study.

Authors:  Francesca Gaccioli; Ulla Sovio; Emma Cook; Martin Hund; D Stephen Charnock-Jones; Gordon C S Smith
Journal:  Lancet Child Adolesc Health       Date:  2018-06-19

6.  Clinical, ultrasound and molecular biomarkers for early prediction of large for gestational age infants in nulliparous women: An international prospective cohort study.

Authors:  Matias C Vieira; Lesley M E McCowan; Alexandra Gillett; Lucilla Poston; Elaine Fyfe; Gustaaf A Dekker; Philip N Baker; James J Walker; Louise C Kenny; Dharmintra Pasupathy
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

7.  Fundal height growth curve for thai women.

Authors:  Jirawan Deeluea; Supatra Sirichotiyakul; Sawaek Weerakiet; Renu Buntha; Chamaiporn Tawichasri; Jayanton Patumanond
Journal:  ISRN Obstet Gynecol       Date:  2013-04-15

8.  Screening for fetal growth disorders by clinical exam in the era of obesity.

Authors:  K R Goetzinger; M G Tuuli; A O Odibo; K A Roehl; G A Macones; A G Cahill
Journal:  J Perinatol       Date:  2012-10-18       Impact factor: 2.521

9.  Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study.

Authors:  Ulla Sovio; Ian R White; Alison Dacey; Dharmintra Pasupathy; Gordon C S Smith
Journal:  Lancet       Date:  2015-09-07       Impact factor: 79.321

10.  Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Sarah Rae Easter; Linda O Eckert; Nansi Boghossian; Rebecca Spencer; Eugene Oteng-Ntim; Christos Ioannou; Manasi Patwardhan; Margo S Harrison; Asma Khalil; Michael Gravett; Robert Goldenberg; Alastair McKelvey; Manish Gupta; Vitali Pool; Stephen C Robson; Jyoti Joshi; Sonali Kochhar; Tom McElrath
Journal:  Vaccine       Date:  2017-12-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.